14 May 2021 16:00
SMITH & NEPHEW PLC
Â
14 May 2021
Â
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
Â
Reason for the notification | |
Initial notification /Amendment | Initial notification |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
Name | Smith & Nephew plc |
LEI | 213800ZTMDN8S67S1H61 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
Description of the financial instrument, type of instrument  | Smith & Nephew plc ordinary shares of USD 0.20 each  |
Identification code | ISIN: GB0009223206 |
Nature of the transaction | Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2020 final dividend payment on 12 May 2021. |
Date of Transaction | 2021 - 05 - 12 |
Place of Transaction | London Stock Exchange (XLON) |
Â
Name (Position) | Director / PDMR | Price | Volume | Aggregated information | Total Ordinary Share Holding following the transaction * | Total Ordinary Share Holding as a % of the Company's ISC following the transaction * |
Bradley Cannon (President Sports Medicine & ENT) | PDMR | £15.269779 | 129.64031 | N/A Single Transaction | 77,295.40344 (including 2,101.64550 in ADS') | 0.00873% |
Phil Cowdy (Chief Business Development & Corporate Affairs Officer) | PDMR | £15.269779 | 112.08811 | N/A Single Transaction | 45,410.28786 | 0.00513% |
Myra Eskes (President APAC Region) | PDMR | £15.269779 | 197.38513 | N/A Single Transaction | 18,332.32816 | 0.00207% |
Simon Fraser (President Advanced Wound Management) | PDMR | £15.269779 | 92.76422 | N/A Single Transaction | 8,615.56333 | 0.00097% |
Mark Gladwell (President Operations & GBS) | PDMR | £15.269779 | 96.46099 | N/A Single Transaction | 96.90438 | 0.00001% |
Melissa Guerdan (Chief Quality & Regulatory Affairs Officer) | PDMR | £15.269779 | 99.85666 | N/A Single Transaction | 9,274.28002 | 0.00105% |
Skip Kiil (President Orthopaedics) | PDMR | £15.269779 | 99.50036 | N/A Single Transaction | 12,128.03780 | 0.00137% |
Catheryn O'Rourke (Chief Legal & Compliance Officer) | PDMR | £15.269779 | 583.31782 | N/A Single Transaction | 82,100.55347 (including 5,818.25734 in ADS') | 0.00928% |
Susan Swabey (Company Secretary) | PDMR | £15.269779 | 190.40720 | N/A Single Transaction | 49,416.24672 | 0.00558% |
Â
* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.
Â
Â
Vickie Reuben
Deputy Company Secretary
Smith & Nephew plc
Â
Tel: +44 (0)1923 477410
Â